Pacira BioSciences Inc

NASDAQ:PCRX  
60.52
+1.34 (+2.26%)
Earnings Announcements

Pacira Biosciences Reports Preliminary Net Product Sales Of $42.2 Million For May 2021

Published: 06/08/2021 13:24 GMT
Pacira BioSciences Inc (PCRX) - Pacira Biosciences Reports Preliminary Net Product Sales of $42.2 Million for May 2021.
Pacira Biosciences Reports Preliminary Net Product Sales of $42.2 Million for May 2021.
Revenue is expected to be $128.74 Million
Adjusted EPS is expected to be $0.68

Next Quarter Revenue Guidance is expected to be $138.26 Million
Next Quarter EPS Guidance is expected to be $0.79

More details on our Analysts Page.